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Abstract
Aims/hypothesis Maternal obesity in pregnancy is associated with cardiovascular disease and mortality rate in the offspring. We
aimed to determine whether maternal obesity is also associated with increased incidence of type 2 and type 1 diabetes in the
offspring, independently of maternal diabetes as a candidate mechanistic pathway.
Methods Birth records of 118,201 children from 1950 to 2011 in the AberdeenMaternity and Neonatal Databank were linked to
Scottish Care Information–Diabetes, the national register for diagnosed diabetes in Scotland, to identify incident and prevalent
type 1 and type 2 diabetes up to 1 January 2012. Maternal BMI was calculated from height and weight measured at the first
antenatal visit. The effect of maternal obesity on offspring outcomes was tested using time-to-event analysis with Cox propor-
tional hazards regression to compare outcomes in offspring of mothers in underweight, overweight or obese categories of BMI,
compared with offspring of women with normal BMI.
Results Offspring of obese (BMI ≥30 kg/m2) and overweight (BMI 25–29.9 kg/m2) mothers had an increased hazard of type 2
diabetes compared with mothers with normal BMI, after adjustment for gestation whenweight was measured, maternal history of
diabetes before pregnancy, maternal history of hypertension, age at delivery, parity, socioeconomic status, and sex of the
offspring: HR 3.48 (95% CI 2.33, 5.06) and HR 1.39 (1.06, 1.83), respectively.
Conclusions/interpretation Maternal obesity is associated with increased incidence of type 2 diabetes in the offspring. Evidence-
based strategies that reduce obesity among women of reproductive age and that might reduce the incidence of diabetes in their
offspring are urgently required.
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Introduction
The short-term pregnancy complications of maternal obesity,
including gestational diabetes, pre-eclampsia, need for
Caesarean section and delivery of large-for-gestational age
infants, are well recognised [1]. There is now increasing
awareness that infants born to obese mothers have longer-
term health problems, including increased risk of premature
cardiovascular disease and premature mortality [2, 3]. As the
prevalence of being overweight or obese among women of
childbearing age is increasing worldwide [4], there is an ur-
gent need to determine any long-term adverse effects for the
offspring.
One key mechanistic pathway that may explain the link
between maternal obesity and offspring cardiovascular dis-
ease [2, 3] is through increased risk of offspring type 2 diabe-
tes. In support of this, higher maternal BMI was associated
with cardiovascular risk factors, including increased fasting
insulin (a surrogate marker of insulin resistance), among off-
spring aged 32 years in the Jerusalem Perinatal Family
Follow-up Study [5]. In longer follow-up of older individuals
born between 1934 and 1944 in the Helsinki Birth Cohort
Study, mothers being overweight was associated with in-
creased risk of offspring diabetes, particularly among female
offspring [3]. In this study, however, the diagnosis of diabetes
was based on the use of medication and so did not include
individuals treated with diet alone and further could not dis-
tinguish between diagnoses of type 2 and type 1 diabetes.
High maternal BMI has been identified as a risk factor for
childhood-onset offspring type 1 diabetes in some studies
[6–8] but not in others [9, 10].
One small case−control study reported a link between ma-
ternal retrospective recall of obesity in pregnancy and
offspring type 2 diabetes in adolescence [11]. Another small
study, conducted in South India, including follow-up of 204
individuals, found that increased maternal weight measured
during pregnancy predicted higher risk of type 2 diabetes in
adult offspring [12], although in this study the mean maternal
weight was 47 kg. Yet, to our knowledge, no studies have
specifically examined whether maternal obesity measured
during pregnancy increases the risk of clinician-diagnosed
type 2 diabetes in the offspring. Further, although 50% of type
1 diabetes develops after age 16 years [13], we are not aware
of any studies examining whether the previously reported as-
sociation between maternal obesity and increased risk of off-
spring childhood-onset type 1 diabetes [6–8] extends to type 1
diabetes diagnosed in adulthood.
We hypothesised that maternal obesity would increase the
incidence of subsequent development of both type 2 and type
1 diabetes in the offspring. To test this hypothesis we exam-
ined the risk of developing a clinically confirmed diagnosis of
type 2 or type 1 diabetes in 118,201 individuals aged 1–
62 years whose mothers’ BMI was measured in pregnancy.
We used a large pregnancy database, the Aberdeen Maternity
and Neonatal Databank (AMND), linked to the Scottish Care
Information–Diabetes (SCI-Diabetes) database, a national
dataset for people with diagnosed diabetes in Scotland.
Methods
In this cohort analysis, the exposure was maternal obesity
during pregnancy and the outcomes in the offspring were:
(1) any diabetes; (2) type 1 diabetes; (3) type 2 diabetes. We
created a linked dataset including data from 118,201 mothers
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and their offspring from the AMND databank linked to the
SCI-Diabetes database after excluding neonatal deaths and for
missing data for offspring sex, gestational age at delivery and
year of diabetes diagnosis (Fig. 1). The AMND is a unique
databank linking all the obstetric and fertility-related events
occurring in women from a defined geographical area with a
relatively stable population, between 1950 and the present day
[14]. Completeness of the database is checked annually
against the number of deliveries recorded in the National
Health Service records office, and validity of data entry is
verified by numerous consistency checks. All women who
delivered a live singleton infant at term (≥37weeks’ gestation)
between 1950 and 2011, and who had their weight recorded at
the first antenatal visit, were identified from the AMND
databank. The women were grouped according to their BMI,
calculated from height and weight measurements taken at the
first antenatal visit, according to WHO criteria: underweight
(BMI <18.5 kg/m2), normal weight (BMI 18.5–24.9 kg/m2),
overweight (BMI 25–29.9 kg/m2) and obese (BMI ≥30 kg/
m2). Relevant details about the index pregnancy were re-
trieved from the AMND, including maternal age, parity,
area-based socioeconomic status, prior self-reported history
of diabetes, history of hypertension, gestation at which weight
was measured, gestation at delivery, and offspring
birthweight, sex and date of birth, from which age at linkage
was calculated.
Offspring birth records were linked to a 2011 extract of
SCI-Diabetes using the Community Health Index number, a
unique individual identifier used on health records in
Scotland, or, if this was unavailable, by probabilistic matching
on surname, date of birth and postcode (zipcode), to identify
individuals with a diagnosis of diabetes.
The SCI-Diabetes database was established at a national
level in 2000 and contains demographic and clinical data rel-
evant to diabetes care. It is populated by daily downloads from
primary and secondary care databases across Scotland, with
increasing completeness since 2004. A validation study
among the subset of people with diabetes mentioned on a
hospital record in 2007 found that 99% were included in the
diabetes register [15]. In SCI-Diabetes, type of diabetes (type
1, type 2, etc.) is recorded by clinicians using a drop-down
menu in the electronic health records. To improve the accura-
cy of this variable for research purposes, an algorithm which
combines information from the clinician-recorded diabetes
type variable and prescription data is used [16, 17]. Thus, in
the current dataset the date of diabetes diagnoses in the off-
spring ranged from 1956 to 2011, with diagnoses available
from birth for all those born after 2000.
Ethics approval for the creation and analysis of the linked
dataset containing no personal identifying information was
obtained from the London–Dulwich Research Ethics
Committee (reference 16/LO/1410). Approvals were also ob-
tained from the steering committee of the AMND, the Scottish
Diabetes Research Network epidemiology subgroup commit-
tee and the privacy advisory committee of Information
Services Division (ISD) Scotland. The pseudonymised dataset
was stored and analysed in the Grampian Data Safe Haven.
Statistical analysis Data were analysed using IBM SPSS
Statistics version 24 (IBM, Armonk, NY, USA). Differences
in maternal and offspring characteristics according to BMI
category were tested using ANOVA for continuous variables
and χ2 tests for categorical variables. The effect of maternal
obesity on offspring incidence of any diabetes, type 1 diabetes
or type 2 diabetes was tested using Cox proportional hazards
models, stratifying for year of birth and adjusting for sex of the
offspring, comparing outcomes in the offspring of mothers
whose pregnancy BMI was underweight, overweight or
obese, with those of women with normal BMI. Analyses were
adjusted for potential confounding factors, including maternal
history of diabetes before pregnancy, maternal history of hy-
pertension, maternal age at delivery, gestation when weight
was measured, deprivation category and parity. For the two
variables with missing data, on deprivation category and ges-
tation when weight was measured, the missing data were cod-
ed to their own categories. In sensitivity analyses we first
repeated the analyses after exclusion of women with a history
of diabetes prior to pregnancy, to study associations between
maternal obesity and offspring outcomes in women without
known diabetes. We then repeated the analyses limiting them
to those born between 1950 and 1976, i.e. with similar
N=118,201
Final dataset
n=13
No offspring sex available
n=627
Neonatal deaths
n=3
No gestational age
at delivery
n=223
No year of diagnosis
of diabetes
N=119,067
women with singleton 
pregnancy
N=119,054
N=118,427
N=118,424
Fig. 1 Flowchart. A linked dataset was created from 118,201 mothers
and their offspring from the AMND databank linked to the SCI-Diabetes
database, after excluding neonatal deaths and missing data for offspring
sex, gestational age at delivery and year of diabetes diagnosis
1414 Diabetologia (2019) 62:1412–1419
duration of follow-up to those in whom we observed a link
between mothers being overweight or obese and offspring
cardiovascular events and mortality rates [2]. In addition, we
repeated the analyses after excluding women with diabetes
prior to pregnancy and with diabetes diagnosed during or after
pregnancy. Finally, we examined interactions by sex and re-
peated the analyses separately for male and female offspring.
These interaction models were adjusted for the main effects of
sex and maternal BMI.
Results
Table 1 shows the characteristics of the 118,201 mothers and
their offspring. Among the mothers, 24.8% were overweight
and 9.5% were obese. The proportion of mothers who were
obese increased fivefold between 1950 and 1959 and 2000
and 2011 from 3.1% (n = 468) to 15.7% (n = 4490)
(p < 0.0001). Obese women were older and had higher parity
and lower deprivation category. The gestation at which weight
was first measured was significantly later in overweight and
obese women. Among the offspring, 732 (0.6%) had a record
of diagnosed diabetes. Among offspring with diabetes, off-
spring of obese mothers had the highest BMI. More male
offspring were diagnosed with diabetes, compared with fe-
male offspring, across all maternal BMI categories.
Maternal obesity and any diabetes in the offspring
Table 2 shows the HRs and 95% CIs for any diabetes in off-
spring according to maternal BMI category. There was a sig-
nificant increase in HR of any diabetes in the offspring of
mothers who were overweight or obese. The associations
were independent of all assessed covariates: after adjustment
for gestation when weight was measured, maternal age at de-
livery, parity, deprivation category, maternal history of diabe-
tes before pregnancy and sex of the offspring, mother being
overweight or obese was still associated with over 1.3- and
1.8-fold increased HR, respectively, of any diabetes in the
offspring.
Maternal obesity and type 1 diabetes in offspring Overall,
410 (0.3%) of the offspring had a diagnosis of type 1 diabetes.
Age at diagnosis of type 1 diabetes ranged from 1 to 52 years.
Table 2 shows the HRs and 95% CIs for type 1 diabetes in the
offspring according to maternal BMI category. In unadjusted
analyses and analyses adjusted for potential confounding fac-
tors, there was no association between mothers being over-
weight or obese and HR of type 1 diabetes in the offspring.
Maternal obesity and type 2 diabetes in offspring Among the
offspring, 319 (0.3%) had a diagnosis of type 2 diabetes. Age
at diagnosis of type 2 diabetes ranged from 10 to 61 years.
Table 2 and Fig. 2 show the HRs and 95% CIs for type 2
diabetes in the offspring according to maternal BMI category.
There was a significant increase in the HR of type 2 diabetes in
the offspring of mothers who were overweight or obese. The
associations were independent of all assessed covariates: after
adjustment for covariates, mothers being overweight or obese
was still associated with over 1.4- and 3.5-fold increased HRs,
respectively, of type 2 diabetes in the offspring.
Sensitivity analyses Associations between maternal obesity
and any diabetes and type 2 diabetes in the offspring remained
significant when the 385 women with a history of diabetes
prior to pregnancy were excluded from the analyses (electron-
ic supplementary material [ESM] Table 1). These associations
also remained significant after excluding all women with dia-
betes before, during or after pregnancy (ESM Table 1). When
restricting the analyses to offspring born between 1950 and
1976, maternal obesity was associated with a 2.3-fold in-
creased HR of offspring type 1 diabetes, as well as a 3.7-fold
increased HR of offspring type 2 diabetes and a 3.3-fold HR of
any diabetes (ESM Table 2). In individuals born after 1977,
maternal obesity was associated with a 2.6-fold increased HR
of type 2 diabetes.
Sex differences in outcomes While the overall interactions
between maternal BMI and sex of the offspring in predicting
offspring HR of any diabetes and type 2 diabetes were mar-
ginal (p = 0.084 and p = 0.076), there were significant interac-
tions specifically for maternal overweight vs normal weight
and sex of the offspring in predicting any diabetes (p = 0.029
for interaction) and type 2 diabetes (p = 0.015 for interaction)
in the offspring. Offspring any diabetes and type 2 diabetes
were more strongly associated with mothers being overweight
in female than in male offspring. The HRs and 95% CIs for
any diabetes and type 2 diabetes in offspring born to over-
weight mothers were 1.50 (1.12, 2.01) and 2.26 (1.37, 3.72)
for female offspring and 1.11 (0.89, 1.37) and 1.11 (0.81,
1.53) for male offspring, respectively. There were no interac-
tions by sex on offspring risk of type 1 diabetes (p ≥ 0.407).
Discussion
In this large cohort study including over 60 years of pregnancy
data linked to the national diabetes dataset we found that, for
pregnant women, being overweight or obese was associated
with an increased incidence of type 2 diabetes in the offspring.
This association with type 2 diabetes may lie on the causal
pathway to explain the link between being overweight or
obese during pregnancy and offspring cardiovascular disease
andmortality rates [2, 3], and it highlights a potential target for
intervention.
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Our finding of a link between being overweight or
obese and type 2 diabetes in the offspring is in accord
with previous observations of associations of pregnant
women being overweight and higher maternal weight with
increased incidence of type 2 diabetes in the offspring [11,
12], and of maternal obesity with markers in the offspring
of increased insulin resistance in childhood [18] and
young adulthood [5, 11, 19]; it is also consistent with
the findings of increased diabetes risk in offspring born
to overweight mothers in the Helsinki Birth Cohort Study
[3]. Although the latter study could not distinguish be-
tween types of diabetes, the association between being
overweight and risk of diabetes was stronger in women
than in men, as observed in our dataset. The reasons for a
sex difference in the findings are unknown but are possi-
bly related to the smaller pancreatic volume [20], and
hence beta cell reserve, in women compared with men,
potentially programmed in utero [21], and the findings
are consistent with those of other studies suggesting wom-
en may be more vulnerable to adverse metabolic program-
ming influences [22, 23]. Evidence suggests increasing
incidence of type 1 diabetes in children born between
1989 and 2003 [24], a time when rates of maternal obesity
were dramatically rising, as also observed in our dataset.
Associations between maternal obesity and childhood-
onset type 1 diabetes have been reported in some studies
[6–8] but not others [9, 10]. Notably, two studies from
Sweden observed an increased incidence of childhood
Table 1 Characteristics of 118,201 mothers and their offspring according to maternal BMI
Characteristica Underweight
n=5283
Normal weight
n=72,329
Overweight
n=29,325
Obese
n=11,264
p
value
Mothers
Age, years 24.8 (5.2) 26.1 (5.5) 27.1 (5.6) 27.7 (5.6) <0.001
Primiparous, n (%) 4146 (78.5) 54,611 (75.5) 20,807 (71.0) 7963 (70.7) <0.001
Deprivation categoryb
1–2, n (%) 1708 (32.3) 22,357 (30.9) 7057 (24.0) 1690 (15.0) <0.001
3–4, n (%) 1481 (28.0) 23,663 (32.7) 10,783 (36.8) 4427 (39.3)
5–6, n (%) 1391 (26.3) 15,477 (21.4) 7000 (23.9) 1784 (15.8)
Gestational weight measured, weeks 12.23 (4.2) 14.22 (6.7) 16.21 (8.6) 15.64 (9.2) <0.001
History of diabetes before pregnancy, n (%) 3 (0.06) 148 (0.2) 157 (0.5) 77 (0.7) <0.001
History of hypertension, n (%) 117 (2.2) 1904 (2.6) 924 (3.2) 383 (3.4) <0.001
Any diabetes, n (%) 152 (2.9) 2033 (2.8) 1284 (4.4) 860 (7.6) <0.001
Offspring
Any diabetes
Total, n (%) 31 (0.59) 437 (0.60) 187 (0.64) 77 (0.68) 0.735
Age at diagnosis, years 32.1 (21.1) 28.5 (19.1) 27.0 (18.3) 26.2 (17.2) 0.393
BMI, kg/m2 27.1 (6.8) 28.4 (7.2) 29.7 (7.5) 32.2 (9.2) <0.001
Male, n (%) 24 (77.4) 309 (70.7) 118 (63.1) 55 (71.4) 0.181
Type 1 diabetes
Total, n (%) 14 (0.27) 242 (0.33) 112 (0.38) 42 (0.37) 0.458
Age at diagnosis, years 11.1 (8.5) 14.3 (10.4) 14.5 (9.6) 13.3 (8.6) 0.621
BMI, kg/m2 22.2 (3.8) 24.7 (5.3) 25.6 (4.5) 26.9 (5.8) 0.015
Male, n (%) 10 (71.4) 155 (64.0) 68 (60.7) 27 (64.3) 0.851
Type 2 diabetes
Total, n (%) 17 (0.32) 193 (0.27) 74 (0.25) 35 (0.31) 0.664
Age at diagnosis, years 49.3 (8.7) 46.2 (11.0) 45.4 (10.8) 41.7 (11.0) 0.068
BMI, kg/m2 30.9 (6.2) 32.7 (6.7) 34.9 (7.5) 37.6 (8.9) 0.001
Male, n (%) 14 (82.4) 153 (79.3) 49 (66.2) 28 (80.0) 0.125
Data are mean (SD), except where indicated as n (%)
a Complete data available for all variables other than deprivation category and gestation weight measured where data were available for 100,397 and
112,340 women, respectively
bDeprivation category according to area socioeconomic status: 1–2, most deprived; 3–4, middle; 5–6, least deprived
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type 1 diabetes in obese mothers without diabetes [6, 8].
We were unable to replicate this finding in our dataset.
Reasons for the differences between the Swedish and
Aberdeen cohorts are unknown and we only found an
association of maternal obesity with offspring type 1 dia-
betes when we restricted the cohort to individuals who
had at least 35 years of follow-up.
The underlying mechanisms linking mothers being
overweight/obese to type 2 diabetes in the offspring are not
known. The fetal overnutrition hypothesis suggests that the ad-
verse in utero environment associated with maternal obesity,
including high circulating levels of glucose, insulin and NEFA,
programmes adverse offspring outcomes [25]. In addition, obe-
sity in pregnancy is associated with complex neuroendocrine,
metabolic and immune/inflammatory changes which likely im-
pact on fetal hormonal exposure and nutrient supply [26, 27]. It
is also thought that epigenetic factors in the intrauterine environ-
ment of obese mothers may initiate beta cell stress, metabolic
dysregulation and earlier onset of type 2 diabetes and cardiomet-
abolic risk [28]. Further, although we adjusted for both prenatal
and postnatal environmental influences in our statistical analyses,
it is extremely likely that there will be residual confounding by
environmental factors that we were unable to measure. The
Hyperglycaemia and Adverse Pregnancy Outcome (HAPO)
study showed an association between increased maternal BMI
and fetal hyperinsulinaemia, independently of maternal
glycaemia [29], supporting an intrauterine influence of maternal
obesity on glucose metabolism in the offspring. Others reported
that rapid growth in the postnatal environment from birth on-
wards, rather than during fetal life, was associated with higher
insulin levels in childhood [30]. Further studies are needed to
understand the contribution of pre- and postnatal mechanisms
linking maternal obesity with type 2 diabetes in the offspring.
The strengths of our study include the large sample size and
the detailed quality of the antenatal records, including mater-
nal history of type 1 diabetes. Our findings remained similar if
we adjusted for maternal diabetes prior to pregnancy in the
analyses or excluded women with a history of diabetes both
prior to and after pregnancy from the analyses. In addition, we
used national population-based health data for diagnosed dia-
betes (SCI-Diabetes), which allowed us to examine outcomes
of both type 2 and type 1 diabetes in the same dataset. A
further major strength of our study is that we included out-
come data for offspring from birth to age 62 years, which
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Fig. 2 Offspring diabetes according tomaternal BMI. U, underweight; N,
normal weight; Ov, overweight; Ob, obese
Table 2 Offspring diabetes ac-
cording to maternal BMI Offspring diabetes HR 95% CI p value Adjusted HR 95% CI p value
Any diabetes
Underweight 0.96 0.67, 1.38 0.829 0.94 0.65, 1.36 0.739
Normal weight 1 1
Overweight 1.23 1.03, 1.46 0.020 1.26 1.06, 1.51 0.009
Obese 1.78 1.38, 2.26 <0.001 1.83 1.42, 2.35 <0.001
Type 1 diabetes
Underweight 0.88 0.51, 1.51 0.639 0.88 0.51, 1.50 0.628
Normal weight 1 1
Overweight 1.14 0.91, 1.42 0.27 1.16 0.92, 1.46 0.204
Obese 1.23 0.88, 1.70 0.23 1.25 0.89, 1.75 0.192
Type 2 diabetes
Underweight 1.07 0.65, 1.76 0.78 1.05 0.64, 1.74 0.835
Normal weight 1 1
Overweight 1.34 1.03, 1.75 0.032 1.39 1.06, 1.83 0.018
Obese 3.33 2.31, 4.78 <0.001 3.48 2.33, 5.06 <0.001
Adjusted HR, analyses were adjusted for maternal history of diabetes before pregnancy, maternal history of
hypertension, maternal age at delivery, gestation when weight was measured, deprivation category, parity and
sex of offspring
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allowed us to explore outcomes across the lifespan. Scottish
Diabetes Survey data indicate that type 2 diabetes prevalence
increases with age to about 11% for 55- to 59-year-olds (i.e.
the oldest age group in this study) [13]. To our knowledge,
there are no other databases worldwide that would allow such
linkage between maternal obesity records in pregnancy and
confirmed diagnosis of diabetes in the offspring. The main
limitation is that as only maternal history of type 1 diabetes
is recorded in the AMND, we were not able to use ‘gestational
diabetes’ or ‘type 2 diabetes’ as covariates to determine
whether there was a difference in offspring outcomes of
mothers who were obese but did not have diabetes during
pregnancy or who were both obese and had gestational or type
2 diabetes. However, we believe the number of women with
pre-existing type 2 diabetes in this dataset would be negligi-
ble, particularly for mothers who were pregnant in the 1950s
and 1960s. In addition, the definition of gestational diabetes
has changed over the study period and more detailed measure-
ments of glucose levels taken during pregnancy would be
required to generate a comparable definition. As hypertension
is part of the metabolic syndrome, we included history of
hypertension in our models as a proxy for insulin resistance.
Data on maternal gestational weight gain were not available,
although a recent study found no evidence that gestational
weight gain influenced risk of childhood type 1 diabetes [8].
A further limitation of our study is that we did not have data
for all offspring on BMI or lifestyle factors (e.g. diet, exercise)
that are known to increase the risk of type 2 diabetes. Indeed, it
is plausible that our observations were due to increased BMI
in the child, either through prenatal programming of BMI or
through shared lifestyle of mother and child. In either case, our
observations are important, as pregnancy represents a poten-
tial time to intervene with health advice for the family.
In conclusion, we showed that, in pregnant women, being
overweight or obese was associated with increased type 2
diabetes incidence in the offspring, independently of perinatal
and sociodemographic covariates and maternal history of di-
abetes. With the rising prevalence of being overweight/obese
in women of childbearing age (for example, recent data indi-
cated that over 60% of women in the USAwere overweight or
obese at the time of conception [4]), our findings have pro-
found public health implications. There is an urgent need to
establish effective approaches to prevention of obesity and
diabetes among mothers and their offspring.
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